CCM
FENC icon

Coldstream Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Coldstream Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-625
Closed -$3.81K – 1860
2025
Q1 		$3.81K Buy
+625
New +$4.01K ﹤0.01% 2807

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coldstream Capital Management's FENC Position: Q2 2025 in Review

Coldstream Capital Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2025, closing a stake of 625 shares — an estimated $3.81K sold.

Coldstream Capital Management first reported a position in FENC in Q1 2025 and held it in 1 quarter. The position peaked at $3.81K in Q1 2025. 78 funds tracked by Wall St. Rank hold FENC as of Q2 2025.

  • Coldstream Capital Management reported no remaining Fennec Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 625 Fennec Pharmaceuticals shares in Q2 2025, an estimated $3.81K.
  • Coldstream Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Fennec Pharmaceuticals position peaked at $3.81K in Q1 2025.
  • 78 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.